Other languages Geron Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 10:27:50 2024-06-06 am EDT			5-day change	1st Jan Change
3.885 ^USD	-2.88%		+11.96%	+84.12%

Jun. 03	Certain Warrants of Geron Corporation are subject to a Lock-Up Agreement Ending on 3-JUN-2024.	CI
Jun. 03	Certain Stock options of Geron Corporation are subject to a Lock-Up Agreement Ending on 3-JUN-2024.	CI

Geron Shares Decline After Q1 Loss Widens	May. 02
Geron Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02
Geron Prices $150 Million Offering of Shares, Pre-Funded Warrants	Mar. 19
Sector Update: Health Care Stocks Ease Late Afternoon	Mar. 15
Sector Update: Health Care Stocks Softer Friday Afternoon	Mar. 15
Sector Update: Health Care	Mar. 15
Top Midday Gainers	Mar. 15
Geron Shares Soar on Positive FDA Advisory Panel's Vote on Imetelstat for Blood Disorder	Mar. 15
Sector Update: Health Care Stocks Edge Higher Premarket Friday	Mar. 15
Sector Update: Health Care	Mar. 15
Investors Turn Cautious Ahead of Next Week's Fed Meeting, Stifling US Equity Futures Pre-Bell	Mar. 15
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday as Rate Cut Hopes Wane	Mar. 15
Top Premarket Gainers	Mar. 15
Geron Corporation Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS	Mar. 14
Geron's blood disorder drug gets FDA advisers' backing	Mar. 14
Sector Update: Health Care Stocks Rise Late Afternoon	Mar. 12
Sector Update: Health Care	Mar. 12
Geron's Imetelstat's Safety a Key Focus for FDA's Oncology Drugs Advisory Committee Meeting; Shares Slump	Mar. 12
Geron's Imetelstat's Safety a Key Focus for FDA's Oncology Drugs Advisory Committee Meeting	Mar. 12
US FDA staff flags concerns about Geron's anemia treatment	Mar. 12

No results for this search